Prediction of In Vivo Interaction Between Triazolam and Erythromycin Based on In Vitro Studies Using Human Liver Microsomes and Recombinant Human CYP3A4

被引：0
|
作者：
Shin-ichi Kanamitsu
Kiyomi Ito
Carol E. Green
Charles A. Tyson
Noriaki Shimada
Yuichi Sugiyama
机构：
[1] University of Tokyo,Graduate School of Pharmaceutical Sciences
[2] Kitasato University,School of Pharmaceutical Sciences
[3] SRI International,Toxicology Laboratory
[4] Daiichi Pure Chemicals Co.,Research and Development Division
[5] LTD.,Graduate School of Pharmaceutical Sciences
[6] University of Tokyo,undefined
来源：
Pharmaceutical Research | 2000年 / 17卷
关键词：
drug interaction; mechanism-based inhibition; triazolam; erythromycin; physiologically-based pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose. To quantitatively predict the in vivo interaction betweentriazolam and erythromycin, which involves mechanism-basedinhibition of CYP3A4, from in vitro studies using human liver microsomes(HLM) and recombinant human CYP3A4 (REC).
引用
收藏
页码：419 / 426
页数：7
相关论文
共 50 条
  • [21] Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes
    Tang, Lan
    Ye, Ling
    Lv, Chang
    Zheng, Zhijie
    Gong, Yun
    Liu, Zhongqiu
    TOXICOLOGY LETTERS, 2011, 202 (01) : 47 - 54
  • [22] Development of Mice Exhibiting Hepatic Microsomal Activity of Human CYP3A4 Comparable to That in Human Liver Microsomes by Intravenous Administration of an Adenovirus Vector Expressing Human CYP3A4
    Kuno, Shuichi
    Sakurai, Fuminori
    Shimizu, Kahori
    Matsumura, Naoya
    Kim, Soonih
    Watanabe, Hitoshi
    Tashiro, Katsuhisa
    Tachibana, Masashi
    Yokoi, Tsuyoshi
    Mizuguchi, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (04) : 296 - 304
  • [23] Comparison of the substrate kinetics of pig CYP3A29 with pig liver microsomes and human CYP3A4
    Yao, Min
    Dai, Menghong
    Liu, Zhaoying
    Huang, Lingli
    Chen, Dongmei
    Wang, Yulien
    Peng, Dapeng
    Wang, Xu
    Liu, Zhenli
    Yuan, Zonghui
    BIOSCIENCE REPORTS, 2011, 31 (03) : 211 - 220
  • [24] 6α-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes
    Araya, Z
    Wikvall, K
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1438 (01): : 47 - 54
  • [25] Amlodipine Metabolism in Human Liver Microsomes and Roles of CYP3A4/5 in the Dihydropyridine Dehydrogenation
    Zhu, Yanlin
    Wang, Fen
    Li, Quan
    Zhu, Mingshe
    Du, Alicia
    Tang, Wei
    Chen, Weiqing
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (02) : 245 - 249
  • [26] Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes - Role of CYP3A4
    Feierman, DE
    Lasker, JM
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (09) : 932 - 939
  • [27] Identification of CYP3A4 as the predominant isoform responsible for the metabolism of ambroxol in human liver microsomes
    Ishiguro, N
    Senda, C
    Kishimoto, W
    Sakai, K
    Funae, Y
    Igarashi, T
    XENOBIOTICA, 2000, 30 (01) : 71 - 80
  • [28] Different Enzyme Kinetics of Midazolam in Recombinant CYP3A4 Microsomes from Human and Insect Sources
    Christensen, Hege
    Mathiesen, Liv
    Postvoll, Lillian W.
    Winther, Bjorn
    Molden, Espen
    DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (03) : 261 - 268
  • [29] Modeling, Prediction, and in Vitro in Vivo Correlation of CYP3A4 Induction
    Shou, Magang
    Hayashi, Mike
    Pan, Yvonne
    Xu, Yang
    Morrissey, Kari
    Xu, Lilly
    Skiles, Gary L.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (11) : 2355 - 2370
  • [30] Prediction of in vivo drug interaction from in vitro systems exemplified by interaction between verapamil and cimetidine using human liver microsomes and primary hepatocytes
    Fischer, U
    Rohde, B
    Wack, R
    Stange, J
    Nitschke, FP
    Adam, U
    Drewelow, B
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (12): : 1150 - 1159
12345